F2 Ventures
Signal active
Investment Firm
Overview
F2 Ventures is a healthcare investment platform focused on arbitrage opportunities across the biotech sector, targeting innovation at the right stage for maximum impact.
Highlights
Founded
2002
Industry
Financial Services
Employees
1-10
Investment
25
Lead Investment
5
Exits
8
Stages
Late Stage Venture, Early Stage Venture, Seed
Investor Type
Venture Capital
Location
Europe
Contact Information
Social
Profile Resume
F2 Ventures, established in 2002 and headquartered in Europe., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Biotechnology, Biopharma, Therapeutics, Financial Services, Venture Capital, Finance, Life Science, Health Care, Oncology, Angel Investment. The organization boasts a portfolio of 25 investments, with an average round size of $104.4M and 8 successful exits. Their recent investments include Chiasma, ARCH Venture Partners, MPM Capital, Ofer Hi-Tech, ProterixBio. The highest investment round they participated in was $277.9B. Among their most notable exits are Chiasma and ARCH Venture Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
F2 Ventures has made 25 investments. Their most recent investment was on May 24, 2023, when ElevateBio raised $401.0M.
F2 Ventures has made 3 diversity investments. Their most recent diversity investment was on Feb 24, 2021, when Orna Therapeutics raised $80.0M.
investments
25
Diversity investments
3
Lead investments
5
Number of exits
8
Investments
25
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 27, 2022 | - | - | 126.6M |
| Sep 20, 2022 | 4M Analytics | Information Technology | 30.0M |
| May 23, 2023 | ReNAgade Therapeutics | Biotechnology | 300.0M |
| May 24, 2023 | ElevateBio | Information Technology | 401.0M |
Exits
8
Funding Timeline
Funding rounds
25
Investors
0
Funds
0
Funding Rounds
25
F2 Ventures has raised 25 rounds. Their latest funding was raised on May 24, 2023 from a Series D - ElevateBio round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 27, 2022 | Post-IPO Equity - AlloVir | - | 126.6M | - |
| Sep 20, 2022 | Series A - 4M Analytics | - | 30.0M | - |
| May 23, 2023 | Series A - ReNAgade Therapeutics | - | 300.0M | - |
| May 24, 2023 | Series D - ElevateBio | - | 401.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.